Cochrane Abstracts
Next‐generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer
Abstract
Objectives
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To evaluate the effectiveness and safety of matched targeted therapies in people with relapsed or metastatic cancer in phase I, II and III trials.
Author(s)
Farasat Kazmi, Nipun Shrestha, Stephen Booth, David Dodwell, Francesca Aroldi, Thomas Foord, Brian D Nicholson, Philip Heesen, Simon Lord, Kheng-Wei Yeoh, Sarah Blagden
Reviewer's Conclusions
Citation
"Next‐generation Sequencing for Guiding Matched Targeted Therapies in People With Relapsed or Metastatic Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432419/all/Next���generation_sequencing_for_guiding_matched_targeted_therapies_in_people_with_relapsed_or_metastatic_cancer. Accessed 30 November 2023.
Next‐generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432419/all/Next���generation_sequencing_for_guiding_matched_targeted_therapies_in_people_with_relapsed_or_metastatic_cancer. Accessed November 30, 2023.
Next‐generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432419/all/Next���generation_sequencing_for_guiding_matched_targeted_therapies_in_people_with_relapsed_or_metastatic_cancer
Next‐generation Sequencing for Guiding Matched Targeted Therapies in People With Relapsed or Metastatic Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 November 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432419/all/Next���generation_sequencing_for_guiding_matched_targeted_therapies_in_people_with_relapsed_or_metastatic_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Next‐generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer
ID - 432419
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432419/all/Next���generation_sequencing_for_guiding_matched_targeted_therapies_in_people_with_relapsed_or_metastatic_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -
